Fig. 5
From: Impact of the national hepatitis B immunization program in China: a modeling study
Cost-effectiveness acceptability curves for immunization strategies. Cost-effectiveness acceptability curves of the infant vaccination strategy (blue curve) and the PMTCT strategy (red curve) under 50% and 30% HBIG coverage and screening rate. USD US dollar, HBIG hepatitis B immunization program, QALY quality-adjusted life year, PMTCT the prevention of mother-to-children transmission